Table 1 Patients demographics and scores

Age, years

64.3 ± 15,9; (65)

68.6 ± 12,2 (69)

0.062

Age > 80, years

n = 74 (15%)

n = 10 (16%)

0.964

male

n = 264 (57%)

n = 46 (72%)

0.020

female

n = 203 (43%)

n = 18 (28%)

0.020

Known malignancy

n = 140 (30%)

n = 31 (48%)

0.003

Chronic heart failure

n = 66 (14%)

n = 15 (23%)

0.052

Chronic pulmonary disease

n = 90 (19%)

n = 14 (22%)

0.623

Chronic heart failure and/or chronic pulmonary disease

n = 137 (29%)

n = 21 (33%)

0.568

RV Diameter [mm], median (range)

40 (34–47)

39 (33–49)

0.861**

LV Diameter [mm], median (range)

38 (32–44)

37 (30–44)

0.557**

RV-/LV-Ratio, median (range)

1.00 ( 0,84–1,30)

1.04 (0,85–1,36)

0.471**

IVC-Reflux grade 0

n = 169 (36%)

n = 23 (36%)

0.969

IVC-Reflux grade I

n = 163 (35%)

n = 21 (33%)

0.742

IVC-Reflux grade II

n = 112 (24%)

n = 14 (22%)

0.710

IVC-Reflux grade III

n = 23 (5%)

n = 6 (9%)

0.142

Pleural effusion

n = 175 (38%)

n = 44 (69%)

< 0,001

Pericardial effusion

n = 35 (8%)

n = 14 (22%)

< 0.001

Ascites

n = 48 (10%)

n = 21 (33%)

< 0.001

hs TnT [ng/ml], median (range)

0.0320 _{(0.0137 – 0.0802)}

0.0805 _{(0.0382 – 0.2272)}

< 0.001**

hs TnT > 0,039ng/ml

n = 137 (29%)

n = 29 (45%)

0.010

Need for vasopressors

n = 33 (7%)

n = 24 (38%)

< 0,001

Central APE

n = 156 (33%)

n = 21 (33%)

0.925

Sub-/Segmental APE

n = 311 (67%)

n = 43 (67%)

0.925

sPESI, median (range)

1 (0–2)

2 (1–2)

< 0.001

BOVA Score, median (range)

2 (0–3)

3 (1–4)

0.011

PEMS, median (range)

0 (0–1)

1 (1–3)

< 0.001

Kumamaru Score, median (range)

85 (68–112)

122 (92–159)

< 0.001

ESC guidelines 2019, median (range)

2 (2–3)

3 (2–3)

< 0.001

CAPE Score, median (range)

1 (0–2)

1 (1–2)

0.016